Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report

Tardive dyskinesia (TD) is a common side effect of antipsychotics, and it remains a persistent and challenging problem. The blonanserin transdermal patch, developed in Japan and launched in September 2019, is the first antipsychotic transdermal treatment. Here, we describe a patient with schizophren...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Shintaro, Morimoto, Yoshiro, Matsuzaka, Yusuke, Nakano, Takeshi, Kanegae, Shinji, Imamura, Akira, Ozawa, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411311/
https://www.ncbi.nlm.nih.gov/pubmed/34357702
http://dx.doi.org/10.1002/npr2.12200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411311/
https://www.ncbi.nlm.nih.gov/pubmed/34357702
http://dx.doi.org/10.1002/npr2.12200

Ejemplares similares